Addiction Treatment Services

Addiction is a chronic disease, which causes individuals to seek “reward” from substance-use or other activities whether or not they may cause harm. Addiction treatment has been in the spotlight as payers, policymakers, and health systems struggle to address the opioid crisis and increasing substance-related mortality rates. As a result, the addiction treatment market is shifting—there is expanded coverage for residential treatment, a push towards greater integration and care coordination, and new competitors entering the market—creating new challenges and opportunities for organizations working in addiction treatment.

Latest Resources

• It’s The Engagement
• Review Finds Limited Evidence For Cannabis In Treating Mental Health Disorders
• Dazos’ New iCampaign Software Automates Email & SMS Marketing Programs To Boost Revenue For Treatment Centers & Behavioral Health Facilities
• Caron Treatment Centers Opens Outpatient Addiction Treatment Center In Delray Beach, Florida
• SimplePractice & Uprise Health Partner To Expand Digital Access To Behavioral Health Professionals
• The Productivity Pivot 
• Study Finds Adherence To Extended-Release Buprenorphine Associated With Lower Health Care Costs In Insured Adults With Opioid Use Disorder
• California Awards $1.18 Billion In Bond Funding To Add 2,500+ Beds & 4,200+ Outpatient Slots
• Artemis Adolescent Healing Center Expands Teen Mental Health Services In Arizona
• GLP-1 Medications Linked To 15%–20% Lower Risk Of Substance Use Disorders In Veterans With Type 2 Diabetes
• Adolescent Cannabis Use Disorder Linked To 52% Higher Schizophrenia Risk Compared To Other Substance Use Disorders
• Private Equity Acquisition Of Addiction Treatment Facilities Linked To Higher Buprenorphine Use, Lower Treatment Retention
• One-Third Of Physician Assistants Have Daily Interactions With People Needing Treatment For Mental Health Disorders
• Catalina Behavioral Health Expands Inpatient Trauma Treatment Services In Tucson
• Health Plan Disenrollment Linked To 51% Higher Mortality Risk For Patients Receiving OUD Medications

See All

GLP-1 Medications Linked To 15%–20% Lower Risk Of Substance Use Disorders In Veterans With Type 2 Diabetes

Researchers from the Veterans Affairs St. Louis Health Care System found that veterans with type 2 diabetes who were prescribed glucagon-like peptide-1 receptor agonists (GLP-1s) had a lower risk of developing substance use disorders (SUDs) compared to those prescribed sodium-glucose cotransporter-2 (SGLT-2) inhibitors, according to a study published in The BMJ. The study was conducted to examine whether GLP-1 medications—originally developed to treat type 2 diabetes and increasingly used for weight management—are associated with differences… Read

• Pennsylvania Naloxone Program Reports Thousands Of Overdose Reversals In 2025
• The Guardianship Question
• Breaking the Revolving Door: How an Intensive Crisis Stabilization Center Is Reducing ER Reliance
• Easterseals MORC Opens Behavioral Health Urgent Care Clinic In Southfield, Michigan
• New York Senate Bill 8309/Assembly Bill 8055: Returns Outpatient Mental Health, Substance Use Disorder, Residential & Rehabilitation Services To Medicaid Fee-For-Service

To sign-up for bi-weekly Mental Health alerts, you must be signed in to your account.